Stephen Ragard

Stephen Ragard has extensive work experience in the finance and pharmaceutical industries. Stephen is currently working at GRAIL, Inc. as a Commercial Forecasting & Analytics professional, a position they started in April 2021. Prior to that, Stephen worked at Barclays as a VP Equity Research in the Specialty Pharmaceuticals sector from March 2019 to April 2021. Before joining Barclays, they served as an Equity Research Associate in Specialty Pharmaceuticals at Mizuho Securities Co., Ltd. from November 2017 to March 2019. Stephen also has experience at Exact Sciences, where they held various roles including Manager, Commercial Analytics from June 2016 to October 2017, Senior Financial Analyst from August 2015 to June 2016, and Financial Analyst from September 2013 to August 2015. Stephen began their career at Stephens Inc., where they worked as an Equity Research Associate from November 2011 to August 2013 and as a Capital Markets Analyst from March 2011 to October 2011.

Stephen Ragard attended Bucknell University from 2006 to 2010, where they pursued a Bachelor of Arts degree in Economics and Chemistry. Stephen also completed a minor in Mathematics during their time at the university. In November 2015, Stephen obtained the Past Chartered Financial Analyst (CFA) Charterholder certification from the CFA Institute.